Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision tag was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's revision history. This does not reflect changes to the study details or results.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content release change without altering the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. No changes to study content or user-facing information.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision note updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check113 days agoChange DetectedThe page shows a minor system revision update from v3.4.1 to v3.4.2, with no changes to the study information, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.